CTI BioPharma (CTIC) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
EPS Growth %: +100.0%
Financial Fact:
Noncontrolling interest: 178K
Today's EPS Names:
NLY, CP, RUSHA, More
EPS Growth %: +100.0%
Financial Fact:
Noncontrolling interest: 178K
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
CTI BioPharma (NASDAQ: CTIC) reported Q1 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.73 million versus the consensus estimate of $9.84 million.
For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
